|
Volumn 259, Issue 8, 2012, Pages 1732-1733
|
Value of MRI as a surrogate marker for PML in natalizumab long-term therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA1A INTERFERON;
METHYLPREDNISOLONE;
NATALIZUMAB;
VIRUS DNA;
ADULT;
BRAIN STEM INJURY;
CASE REPORT;
CEREBROSPINAL FLUID;
CONTRAST ENHANCEMENT;
DISEASE COURSE;
DISEASE MARKER;
DYSARTHRIA;
FEMALE;
FRONTAL LOBE;
HUMAN;
JC VIRUS;
LETTER;
LONG TERM CARE;
MULTIPLE SCLEROSIS;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PARAPLEGIA;
PLASMAPHERESIS;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
RELAPSE;
SYMPTOM;
VERBAL MEMORY;
VIRUS LOAD;
WHITE MATTER;
ADULT;
ANTIBODIES, MONOCLONAL, HUMANIZED;
BIOLOGICAL MARKERS;
FEMALE;
HUMANS;
LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL;
MAGNETIC RESONANCE IMAGING;
TIME FACTORS;
|
EID: 84867334537
PISSN: 03405354
EISSN: 14321459
Source Type: Journal
DOI: 10.1007/s00415-012-6426-5 Document Type: Letter |
Times cited : (23)
|
References (5)
|